Full Press Release Details
Incyte to Report Third Quarter Financial Results
WILMINGTON, Del.--(BUSINESS WIRE)--Oct. 8, 2026--Incyte(Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for8:00 a.m. ETonThursday, October 29, 2026.
The schedule for the press release and conference call/webcast is as follows:
• Q3 2026 Press Release:October 29, 2026, at7:00 a.m. ET
• Q3 2026 Conference Call:October 29, 2026, at8:00 a.m. ET
• Domestic Dial-In Number: 877-407-3042
• International Dial-In Number: 201-389-0864
• Conference ID Number: 13763051
If you are unable to participate, a replay of the conference will be available for thirty days. The replay dial-in number for theU.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference identification number 13763051.
A live webcast with slides can be accessed atInvestor.Incyte.comand will be available for replay for ninety days.
About IncyteIncyte is redefining what’s possible in biopharmaceutical innovation. Through deep scientific expertise and a relentless focus on patients, we have built an established portfolio of first-in-class medicines and an extensive portfolio of next-generation medicines across our key franchises: Hematology, Oncology and Inflammation & Autoimmunity.
To learn more, visitIncyte.comandInvestor.Incyte.com. Follow us on social media:LinkedIn,X, andInstagram.
View source version on businesswire.com:https://www.businesswire.com/news/home/20261008696942/en/
Incyte ContactsMediamedia@incyte.comInvestorsir@incyte.com
Source: Incyte